Founded in 2005, ORTHOCON is a startup therapeutic device company that develops, manufactures, markets and sells innovative surgical products that stop the bleeding from and deliver drugs to bone. In 2010, ORTHOCON launched its first FDA-cleared product, the HEMASORB Absorbable Bone Hemostat Matrix. ORTHOCON believes its products have the potential to provide significant benefits to millions of patients each year.
Looking for a particular ORTHOCON employee's phone or email?
The ORTHOCON annual revenue was $8 million in 2026.
Richard Kronenthal is the Founder, VP, CSO of ORTHOCON.
2 people are employed at ORTHOCON.
ORTHOCON is based in Irvington, New York.
The NAICS codes for ORTHOCON are [32, 3254, 325, 32541].
The SIC codes for ORTHOCON are [384, 38].